ISSN 2472-016X

Journal of Orthopedic Oncology
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Review Article   
  • J Orthop Oncol 9: 192,
  • DOI: 10.4172/2472-016X.100192

Short Review on Doxorubicin Treatment Stabilizes Metastatic Bone Cancer

Garcia Valles*
Department of Pathology, Ohio State University, USA
*Corresponding Author : Garcia Valles, Department of Pathology, Ohio State University, USA, Email: valles007180@usal.es

Received Date: Jan 02, 2023 / Published Date: Jan 30, 2023

Abstract

In breast cancer, complete bone marrow infiltration accompanied by severe pancytopenia is extremely uncommon. After metastatic breast cancer develops, bone marrow metastasis may frequently occur. However, it is uncommon to observe bone marrow failure as a sign of this disease. The safest and most effective way to treat patients with severe pancytopenia caused by metastatic solid tumor involvement is poorly studied. The patient’s thrombocytopenia was particularly concerning in this instance, necessitating daily platelet transfusions. Cytotoxic chemotherapy was also feared to worsen the patient’s thrombocytopenia and increase the risk of bleeding. The patient’s remarkable response to chemotherapy, which resulted in a complete recovery of her platelets, is also extremely unusual. Even though our patient had a low baseline platelet level, continuous doxorubicin was able to successfully “unpack” the bone marrow without increasing the need for more frequent platelet transfusions or the risk of catastrophic bleeding. Due to the rarity of this presentation, it is currently unknown if the majority of comparable patients experience near-full recovery of hematopoietic function upon beginning the appropriate systemic treatment for metastatic disease.

Citation: Valles G (2023) Short Review on Doxorubicin Treatment Stabilizes Metastatic Bone Cancer. J Orthop Oncol 9: 192. Doi: 10.4172/2472-016X.100192

Copyright: © 2023 Valles G. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Top